The cyclin kinase inhibitor p21WAF1/CIP1 is required for glomerular hypertrophy in experimental diabetic nephropathy Mouhannad Al-Douahji, James Brugarolas, Paul A.J. Brown, Catherine O. Stehman-Breen, Charles E. Alpers, Stuart J. Shankland Kidney International Volume 56, Issue 5, Pages (November 1999) DOI: /j x Copyright © 1999 International Society of Nephrology Terms and Conditions Terms and Conditions
Figure 1 Kidney International , DOI: ( /j x) Copyright © 1999 International Society of Nephrology Terms and Conditions Terms and Conditions
Figure 2 Kidney International , DOI: ( /j x) Copyright © 1999 International Society of Nephrology Terms and Conditions Terms and Conditions
Figure 3 Kidney International , DOI: ( /j x) Copyright © 1999 International Society of Nephrology Terms and Conditions Terms and Conditions